Published Online
on November 18, 2002

A more recent version of this article appeared on December 3, 2002

This Article Full Text (PDF) All Versions of this Article: 106/23/2946    most recent 01.CIR.0000040999.00692.F3v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, J. M. Articles by Weldon, A. Search for Related Content PubMed PubMed Citation Articles by Stewart, J. M. Articles by Weldon, A. Related Collections Autonomic, reflex, and neurohumoral control of circulation Other Vascular biology

Submitted on June 19, 2002
Revised on September 17, 2002
Accepted on September 19, 2002

Clinical and Physiological Effects of an Acute -1 Adrenergic Agonist and a -1 Adrenergic Antagonist in Chronic Orthostatic Intolerance

Julian M. Stewart MD, PhD^*, Jose Munoz MD, and Amy Weldon RDCS

From the Departments of Pediatrics (J.M.S., A.W., J.M.) and Physiology (J.M.S.), New York Medical College, Valhalla, NY.

^* To whom correspondence should be addressed. E-mail: stewart{at}nymc.edu.

Background—Adrenergic agents are commonly used in the treatment of chronic orthostatic intolerance with postural tachycardia syndrome (POTS). POTS may be associated with increased limb blood flow ("high flow") and defective orthostatic vasoconstriction or decreased limb blood flow ("low flow") and potentially with small blood volume.

Methods and Results—We investigated the consequences of short-term intravenous administration of an -1 adrenergic agonist, phenylephrine, and a -1 adrenergic antagonist, esmolol, in 14 patients with POTS aged 13 to 19 years. Indices of heart rate and blood pressure variability, peripheral blood flow, and arterial resistance were assessed, and the capacitance relation was computed for every subject using venous occlusion plethysmography. Patients were tilted to 35° upright while medicated and while unmedicated, and measurements were repeated. Phenylephrine improved orthostatic tolerance and normalized hemodynamics and indices of heart rate/blood pressure variability while supine and while upright, producing significant peripheral vasoconstriction and venoconstriction (20% capacitance change). Esmolol did not improve orthostatic tolerance or hemodynamics. A subgroup of low-flow POTS patients had exaggerated venoconstriction to phenylephrine (50% capacitance change) but others had no response.

Conclusions—Phenylephrine, but not esmolol, improves orthostatic tolerance and hemodynamics in POTS. This lends support to the use of oral -1 agonists in the treatment of patients with chronic orthostatic intolerance.

Key words: blood flow • vasoconstriction • heart rate

This article has been cited by other articles:

				A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF]

				S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682. [Abstract] [Full Text] [PDF]

				S. R. Raj, B. K. Black, I. Biaggioni, P. A. Harris, and D. Robertson Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome Circulation, May 31, 2005; 111(21): 2734 - 2740. [Abstract] [Full Text] [PDF]

				S. M. Romano, C. Lazzeri, M. Chiostri, G. F. Gensini, and F. Franchi Beat-to-beat analysis of pressure wave morphology for pre-symptomatic detection of orthostatic intolerance during head-up tilt J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1891 - 1897. [Abstract] [Full Text] [PDF]

				J. M. Stewart and L. D. Montgomery Regional blood volume and peripheral blood flow in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1319 - H1327. [Abstract] [Full Text] [PDF]

				A. Aries, P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity PNAS, May 4, 2004; 101(18): 6975 - 6980. [Abstract] [Full Text] [PDF]

				J. M. Stewart, M. S. Medow, L. D. Montgomery, and K. McLeod Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1216 - H1222. [Abstract] [Full Text] [PDF]